← Browse by Condition
Medical Condition
radiotherapy side effect
Total Trials
8
Recruiting Now
8
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for radiotherapy side effect sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — radiotherapy side effect Clinical Trials
How many clinical trials are currently recruiting for radiotherapy side effect?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for radiotherapy side effect, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for radiotherapy side effect?
radiotherapy side effect research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a radiotherapy side effect clinical trial?
Eligibility criteria for radiotherapy side effect trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05724004
Recruiting
Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NSCLC With ALK-rearrangement (A-SAB)
Enrollment
70 pts
Location
Sweden
Sponsor
Karolinska University Hospital
NCT03378856
Recruiting
Evaluation of Technological Innovation in Radiotherapy
Enrollment
1,500 pts
Location
Canada
Sponsor
Centre hospitalier de l'Univer...
NCT05224297
Recruiting
Patient Experience Data in Radiation Oncology
Enrollment
6,000 pts
Location
Austria
Sponsor
Medical University of Vienna
NCT04889924
Recruiting
ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer
Enrollment
820 pts
Location
Australia, Spain
Sponsor
Hospital Universitari de Bellv...
NCT06618703
Recruiting
Brain Irradiation for Childhood Cancer - Endocrine Monitoring During the First Years
Enrollment
230 pts
Location
France
Sponsor
University Hospital, Angers
NCT05786742
Recruiting
Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.
Enrollment
205 pts
Location
Canada
Sponsor
CHU de Quebec-Universite Laval
NCT03742687
Recruiting
Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC
Enrollment
151 pts
Location
Denmark
Sponsor
Danish Lung Cancer Group
NCT05165056
Recruiting
Photobiomodulation Therapy in the Prevention and Management of Radiotherapy-induced Vaginal Toxicity
Enrollment
62 pts
Location
Belgium
Sponsor
Jessa Hospital
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology